Annals of internal medicine
-
Bureau C, Thabut D, Jezequel C, et al. The use of rifaximin in the prevention of overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt: a randomized controlled trial. Ann Intern Med. 2021;174:633-40. 33524293.
-
Letter Case Reports
Severe Joint Involvement in VEXAS Syndrome: A Case Report.